PRFM
Cellenis® PRFM (Platelet Rich Fibrin Matrix) is a fibrin gel matrix that is derived by combining Cellenis® PRP with autologous thrombin. Cellenis® Thrombin Rich Serum (TRS) is a major byproduct of Cellenis® PRF.
PRFM produced by PRP activation with TRS, provides a flexible platform that enables control of PRP concentration. Platelet concentration of at least one million/microliter is considered therapeutically effective. The platelet concentration affects the matrix viscosity and different growth factor release patterns. PRP activation with autologous thrombin shows an immediate release of PDGF and TGF that remains stable over time. VEGF demonstrates an increasing trend from 15 minutes up to 24 hours. PRFM platform enables also the control over the matrix diameter.
Why Cellenis®?
Cellenis® accelerates bone and soft tissue formation
Safe and convenience
No risk of rejection being an autologous material
Increases tissues generation due to growth factors release
Improves and hastens healing and regeneration; including epithelial wound healing – recovery is nearly 6 times faster
Jump starts osteogenesis
Faster preparation of implant site
Cellenis® seals the wound from infectious agents
Safe and convenience
No risk of rejection being an autologous material
Cellenis® requires small amount of blood
Safe and convenience
No risk of rejection being an autologous material
Cellenis® system advantages:
Quick and Simple
Single 10 minutes centrifugation to obtain pure PRP 10-20 minutes centrifugation to obtain pure PRF, without red blood cells and granulocytes
Flexible and easy to use
Enables PRP concentration by simply withdrawing the PPP
Unique sizes of tubes:
Cellenis® PRP 11ml and 22ml Cellenis® PRF 12ml and 23ml
Closed system
FDA approved (510K for orthopedic applications)
CE approved (class IIb)
PRFM Preparation
1
2
3
4
5
6
NEW
HEADQUARTERS
11st Floor, Healthaid House
Marlborough Hill
Harrow, HA1 1UD, United Kingdom
Email: sales@cellenis.com
Contact us
Site by MoranSotto & Arctica Digital | © All Rights Reserved to Estar Technologies Ltd 2023